Business Context and Reporting Period
This Form 8-K filing by Bone Biologics Corp (BBLG) reports a corporate governance event dated January 8, 2024. The company is incorporated in Delaware and trades on The Nasdaq Stock Market LLC.
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses exclusively on board composition changes.
Material Changes
- Board Appointment: Robert E. Gagnon was appointed to the Board of Directors effective January 8, 2024.
- Board Resignation: Erick Lucera resigned from the Board on December 27, 2023, effective upon Mr. Gagnon's appointment.
- Committee Assignments: Mr. Gagnon will serve as Chair of the Audit Committee and as a member of the Compensation Committee and the Nominating and Corporate Governance Committee.
- Compensation: Mr. Gagnon will be compensated in the same manner as other directors.
Management Commentary and Background
Mr. Gagnon brings over 20 years of financial and commercial experience. His background includes roles as Operating Partner at Gurnet Point Capital, Chief Business Officer and CFO at Verastem Oncology, CFO at Harvard Bioscience, Inc., and Executive Vice President/CFO/Treasurer at Clean Harbors, Inc. He previously held senior positions at Biogen Idec, Deloitte & Touche, and PricewaterhouseCoopers. He currently serves on the boards of Verastem Oncology and Purple Biotech.
The filing states there are no undisclosed transactions with Mr. Gagnon requiring disclosure under Item 404(a) of Regulation S-K.
Key Facts for Investor Verification
- Verify the effective date of Erick Lucera's resignation and Robert Gagnon's appointment (January 8, 2024).
- Confirm Mr. Gagnon's new committee roles, specifically his chairmanship of the Audit Committee.
- Review the accompanying press release (Exhibit 99.1) for additional context on the leadership transition.
- Note that this filing contains no financial performance data; refer to the most recent 10-K or 10-Q for financial metrics.